(NASDAQ: BLFS) Biolife Solutions's forecast annual revenue growth rate of 22.45% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 7.9%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.67%.
Biolife Solutions's revenue in 2025 is $74,005,000.On average, 12 Wall Street analysts forecast BLFS's revenue for 2025 to be $4,779,126,898, with the lowest BLFS revenue forecast at $4,482,583,083, and the highest BLFS revenue forecast at $5,146,544,637. On average, 11 Wall Street analysts forecast BLFS's revenue for 2026 to be $5,454,210,651, with the lowest BLFS revenue forecast at $5,072,396,646, and the highest BLFS revenue forecast at $5,763,321,106.
In 2027, BLFS is forecast to generate $6,695,467,277 in revenue, with the lowest revenue forecast at $6,197,616,481 and the highest revenue forecast at $7,113,873,797.